User menu

A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.

Bibliographic reference Zaghla, H ; Selby, R R ; Chan, L S ; Kahn, J A ; Donovan, J A ; et. al. A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.. In: Alimentary Pharmacology and Therapeutics, Vol. 23, no.4, p. 513-520 (2006)
Permanent URL
  1. McAlister V, Orthotopic liver transplantation using low-dose tacrolimus and sirolimus, 10.1053/jlts.2001.26510
  2. Trotter J.F, Sirolimus in liver transplantation, 10.1016/s0041-1345(03)00234-3
  3. Murgia M, Kidney Int, 49, 209 (1996)
  4. Wright Teresa L., Treatment of patients with hepatitis C and cirrhosis, 10.1002/hep.1840360724
  5. Chang George J., Mahanty Harish D., Quan David, Freise Chris E., Ascher Nancy L., Roberts John P., Stock Peter G., Hirose Ryutaro, Experience with the use of sirolimus in liver transplantation—use in patients for whom calcineurin inhibitors are contraindicated, 10.1053/jlts.2000.19023
  6. Nair S, Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation, 10.1053/jhep.2002.33160
  7. Pridöhl O., Heinemann K., Hartwig T., Witzigmann H., Lamesch P., Fangmann J., Berr F., Hauss J., Kohlhaw K., Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results, 10.1016/s0041-1345(01)02373-9
  8. Kniepeiss D, Iberer F, Grasser B, Schaffellner S, Tscheliessnigg K.H, Sirolimus in patients after liver transplantation, 10.1016/s0041-1345(03)00082-4
  9. Watson Christopher J.E., Friend Peter J., Jamieson Neville V., Frick Thomas W., Alexander Graeme, Gimson Alexander E., Calne Roy, SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATION : , 10.1097/00007890-199902270-00002
  10. Poordad F, Hepatology, 36, 186A (2002)
  11. Nair S, Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients, 10.1053/jlts.2003.50026
  12. Perrillo R, Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B, 10.1053/jhep.2002.34294
  13. Cotterell Adrian H, Fisher Robert A, King Anne L, Gehr Todd W B, Dawson Sherfield, Sterling Richard K, Stravitz R Todd, Luketic Velimir A, Sanyal Arun J, Shiffman Mitchell L, Posner Marc P, Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent, 10.1034/j.1399-0012.16.s7.7.x
  14. Dhir R, Hepatology, 36, 187A (2002)
  15. Dunkelberg J, Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications, 10.1053/jlts.2003.50079
  17. Montalbano Marzia, Neff Guy W., Yamashiki Noriyo, Meyer Douglas, Bettiol Marina, Slapak-Green Gabriella, Ruiz Phillip, Manten Emory, Safdar Kamran, O’Brien Christopher, Tzakis Andreas G., A Retrospective Review of Liver Transplant Patients Treated with Sirolimus from a Single Center: An Analysis of Sirolimus-Related Complications : , 10.1097/
  18. Sousa J. E., Costa M. A., Abizaid A., Abizaid A. S., Feres F., Pinto I. M. F., Seixas A. C., Staico R., Mattos L. A., Sousa A. G. M. R., Falotico R., Jaeger J., Popma J. J., Serruys P. W., Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries : A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study, 10.1161/01.cir.103.2.192
  19. Guilbeau Jane M, Delayed Wound Healing with Sirolimus after Liver Transplant, 10.1345/aph.1a128
  20. Trotter J, Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus, 10.1053/jlts.2001.23916
  21. Firpi R. J., Tran T. T., Flores P., Nissen N., Colquhoun S., Shackleton C., Martin P., Vierling J. M., Poordad F. F., Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent, 10.1111/j.1365-2036.2004.01923.x